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In Brief
Piezo1 is a stretch-activated ion channel
expressed in the endothelium and its
deletion alters vascular architecture.
However, its role in arterial myocytes
remains unknown. Retailleau et al. show
that smooth muscle Piezo1 is
dispensable for the arterial myogenic
tone but involved in the remodeling of
small arteries upon hypertension.
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The mechanically activated non-selective cation
channel Piezo1 is a determinant of vascular architec-
ture during early development. Piezo1-deficient em-
bryos die at midgestation with disorganized blood
vessels. However, the role of stretch-activated ion
channels (SACs) in arterial smooth muscle cells in
the adult remains unknown. Here, we show that
Piezo1 is highly expressed in myocytes of small-
diameter arteries and that smooth-muscle-specific
Piezo1 deletion fully impairs SAC activity. While
Piezo1 is dispensable for the arterial myogenic
tone, it is involved in the structural remodeling of
small arteries. Increased Piezo1 opening has a tro-
phic effect on resistance arteries, influencing both
diameter and wall thickness in hypertension. Piezo1
mediates a rise in cytosolic calcium and stimulates
activity of transglutaminases, cross-linking enzymes
required for the remodeling of small arteries. In
conclusion, we have established the connection be-
tween an early mechanosensitive process, involving
Piezo1 in smooth muscle cells, and a clinically rele-
vant arterial remodeling.
INTRODUCTION
The molecular identity of non-selective stretch-activated ion
channels (SACs) has long remained amystery (Nilius, 2010; Ped-
ersen and Nilius, 2007). Only recently, Piezo1 and Piezo2 were
shown to be essential components of distinct SACs (Coste
et al., 2010). Piezo1 is a pore-forming subunit, as demonstrated
by functional reconstitution into artificial bilayers (Coste et al.,
2012). Piezo1 exogenous depolarizing currents can be activated
in the whole cell configuration upon pressure stimulation with a
glass stylus, by fluid flow, by substrate deflection, or in theCell Repcell-attached patch configuration by applying a negative pres-
sure (Bae et al., 2011; Coste et al., 2010; Gottlieb et al., 2012;
Li et al., 2014; Peyronnet et al., 2013; Poole et al., 2014; Ranade
et al., 2014). In terms of permeability, Na+, K+, Ca2+, and Mg2+ all
permeate the channel, with a slight preference for Ca2+ (Coste
et al., 2010).
Global knockout of Piezo1 is embryonically lethal, thus indi-
cating an important role for this mechanosensitive ion channel
in early development (Li et al., 2014; Ranade et al., 2014). Piezo1
is expressed in the endothelium of developing blood vessels,
and its genetic deletion profoundly alters vascular architecture
(Li et al., 2014; Ranade et al., 2014). Piezo1 expression in the
endothelium confers sensitivity to shear stress, resulting in a cal-
cium influx in response to increased fluid flow (Li et al., 2014; Ra-
nade et al., 2014). Loss of Piezo1 in endothelial cells leads to
altered stress fiber organization and cell orientation in response
to shear stress (Li et al., 2014; Ranade et al., 2014). These
elegant findings indicate that shear stress activation of endothe-
lial Piezo1 is required for the proper development of blood ves-
sels (Li et al., 2014; Ranade et al., 2014).
The opening of SACs at the plasma membrane of smooth
muscle cells has been proposed as a triggering mechanism for
the myogenic response (Beech, 2005; Brayden et al., 2008; Da-
vis and Hill, 1999; Folgering et al., 2008; Hill et al., 2006). The
myogenic response is a tonic vasoconstriction of small-diameter
arteries in response to an increase in intraluminal pressure and
serves to maintain a constant blood flow within a wide range of
blood pressures and is required for the establishment of a basal
tone upon which vasorelaxing agents may act (Davis and Hill,
1999; Hill et al., 2006). While, various inhibitors of SACs have
been shown to significantly reduce the amplitude of the myo-
genic response in different vascular beds (Drummond et al.,
2004; Earley et al., 2004; Jernigan and Drummond, 2006; Taken-
aka et al., 1998a, 1998b; Welsh et al., 2002), non-specific effects
of these pharmacological agents cannot be entirely ruled out.
Moreover, the molecular identity of SACs in arterial myocytes
remains obscure, with a possible involvement of epithelial
Na+ channel (ENaC) and/or transient receptor potential (TRP)orts 13, 1161–1171, November 10, 2015 ª2015 The Authors 1161
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Figure 1. Piezo1 Expression in Arterial
Smooth Muscle Cells
(A) qPCR data showing Piezo1 and Piezo2 mRNA
expression (relative to the expression of topo-
isomerase 1; TOP1) in de-endothelized caudal ar-
teries from sm22Cre Piezo1+/+ mice (white bars) or
sm22Cre Piezo1/ mice (black bars). Number of
mice is indicated. Data represent mean ± SEM.
(B) LacZ staining of aorta, renal artery, and caudal
artery from Piezo1LacZ/+ mice. Lack of staining is
shown on the right side for a control Piezo1+/+
caudal artery.
(C) LacZ staining of a caudal arterial section from a
Piezo1LacZ/+ mouse. The bottom panel shows a
magnification of the boxed area.
(D) LacZ staining of cerebral arteries. The circle of
Willis and cerebral arteries stained in blue are
visible in the Piezo1LacZ/+ mouse (right panel),
compared to a control Piezo1+/+ mouse brain (left
panel). Bottom pictures illustrate a magnification of
the medial cerebral artery, comparing Piezo1+/+
(left) with Piezo1LacZ/+ (right) mice (boxed in the
upper pictures).
(E) Discrete LacZ staining in a renal artery section
from a Piezo1LacZ/+ mouse. The bottom panel
shows a magnification of the boxed area.
See also Figure S1.subunits (Drummond et al., 2004; Earley et al., 2004; Jernigan
and Drummond, 2006; Lee et al., 2007; Park et al., 2003; Taken-
aka et al., 1998a, 1998b; Welsh et al., 2002).
In addition to an acute myogenic regulation of arterial diam-
eter, resistance arteries also have the ability to regulate their
caliber during chronic hypertension by a phenomenon called
arterial remodeling, operating on a timescale of several days
(Bakker et al., 2005, 2008; Martinez-Lemus et al., 2009; Mulvany,
2002). Arterial remodeling is a structural adaptation of the vessel
wall to hemodynamic stimuli (Bakker et al., 2005, 2008; Marti-
nez-Lemus et al., 2009; Mulvany, 2002). In chronic hypertension,
conduit arteries undergo an hypertrophic remodeling, while
resistance arteries show inward eutrophic remodeling, with a
repositioning of smooth muscle cells around a smaller lumen
diameter in the absence of hypertrophy (Mulvany, 2002). Those
changes in wall thickness and diameter contribute, according
to the law of Laplace (s = Pri/h, where s = wall stress, P = pres-
sure, ri = inner arterial radius, and h = wall thickness), to the arte-
rial wall tensional homeostasis (Khavandi et al., 2009; Mulvany,
2002). Importantly, remodeling of small arteries has been linked
to cardiovascular morbidity and mortality (Mathiassen et al.,
2007; Rizzoni et al., 2003). Disorders in the structure and function
of resistance arteries raise capillary pressure and may cause
downstream organ damage, as occurring in diabetic nephropa-
thy (Khavandi et al., 2009). The molecular mechanisms impli-
cated in the remodeling of resistance arteries during hyperten-
sion are only starting to emerge (Bakker et al., 2005, 2008;
Martinez-Lemus et al., 2009; Mulvany, 2002). Recent findings
indicate that activation of the crosslinking enzyme transglutami-
nase 2 is involved in the remodeling of small arteries in hyper-
tensive conditions (Bakker et al., 2005; Engholm et al., 2011;
Huelsz-Prince et al., 2013).1162 Cell Reports 13, 1161–1171, November 10, 2015 ª2015 The AuHere, usingacombinationof smooth-muscle-specificknockout
mouse models, we explored the functional role of Piezo1 in the
adult circulation. We show that, while Piezo1 is dispensable for
the arterialmyogenic tone, it is centrally involved in the remodeling
of small arteries.
RESULTS
Smooth-Muscle-Specific Piezo1 Knockout Mouse
Model
qPCR analysis revealed that Piezo1, unlike Piezo2, is highly
expressed in the cutaneous caudal artery (Figure 1A). We
used the sm22Cre recombinase to specifically delete Piezo1
in smooth muscle cells of C57BL/6 male mice (sm22Cre
Piezo1/) (Figures S1A–S1F). We observed a robust knock-
down of Piezo1 in the caudal artery without compensation
by Piezo2 expression (Figure 1A). Mouse weight, tibial
length, and viability were not affected by specific deletion
of Piezo1 in smooth muscle cells (Figures S1G and S1H).
Moreover, arterial pressure was not significantly modified in
the absence of Piezo1, in awake or anesthetized mice (Fig-
ures S1K–S1M).
Taking advantage of a LacZ Piezo1 reporter mouse, we
observed a remarkably strong expression of Piezo1 (shown in
blue) in the media of small-diameter arteries, with the strongest
signals seen in the cutaneous caudal artery and cerebral arteries
(Figures 1B–1D). Indeed, isolated smooth muscle cells from the
caudal resistance artery were strongly positive for Piezo1, as
visualized by intense LacZ blue staining (Figures S1E and S1F).
In contrast, a very low expression was detected in large-diam-
eter conduit arteries, including the aorta or the main renal artery
(Figures 1B and 1E).thors
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Figure 2. SAC Activity in Caudal Artery Myocytes Critically Requires
Piezo1
(A) Non-selective SAC currents from a sm22Cre Piezo1+/+ caudal artery my-
ocyte were elicited in the cell-attached patch configuration by applying pulses
of negative pressure in the patch pipette (bottom traces). Channel activity was
recorded at a holding potential of 80 mV (top traces).
(B) Current-to-voltage relationship for single SACs in isolated myocytes from
sm22Cre Piezo1+/+ caudal artery myocytes (n = 5). i, single-channel current
amplitude; V, voltage; g, single-channel conductance.
(C) Mean SAC current amplitude in sm22Cre Piezo1+/+ (white circles) and
sm22Cre Piezo1/ (black circles) myocytes isolated from the caudal artery.
For comparison, mean SAC current amplitude recorded in isolated myocytes
from sm22Cre Piezo1+/+ aorta (white squares) and sm22Cre Piezo1+/+ renal
artery (white triangles) is shown. Number ofmyocytes is indicated. SAC activity
was measured in the cell-attached patch-clamp configuration in response to
negative pressure pulses at a holding potential of80 mV (as shown in A). The
fitting parameters were P0.5: 26.3 and k: 7.5 for caudal artery sm22Cre
Piezo1+/+.
Data represent mean ± SEM. ***p < 0.001.
See also Figure S2.These findings indicate that Piezo1 is present at the adult
stage in the smooth muscle of small arteries that participate
actively in the regulation of peripheral resistance, as well as
in the cerebral circulation. Moreover, Piezo1 in myocytes of
small-diameter arteries is dramatically knocked down in the
sm22Cre Piezo1/ mouse model.
Piezo1 Is Critically Required for SAC Activity in Arterial
Myocytes
We measured the activity of non-selective SACs in freshly iso-
lated myocytes from the caudal artery using cell-attached patch
clamp recordings (Figure 2A). SACs only partially inactivated
during a maintained pressure pulse, and they reversed at about
0 mV, and the single-channel conductance was estimated to be
about 35 pS (Figures 2A and 2B; Figure S2B). In line with the dif-
ferential LacZ expression profile of Piezo1, SAC activity was
significantly higher in smooth muscle cells derived from the
caudal artery (128/187 active patches for sm22Cre Piezo1+/+)
compared to that elicited in myocytes from the aorta (1/18) or
renal arteries (7/34) (Figure 2C). Most importantly, SAC activityCell Repin caudal arterymyocytes was dramatically reduced upon homo-
zygote deletion of Piezo1 (9/114 active patches for sm22Cre
Piezo1/; Figures 2C and S2A).
These findings demonstrate that Piezo1 is critically required
for non-selective SAC activity in smooth muscle cells of the
caudal artery.
Piezo1 Is Dispensable for the Caudal Artery
Myogenic Tone
One possiblemechanism for initiation of themyogenic tone is the
opening of SACs in arterial smooth muscle cells in response to
an increase in wall tension (for reviews, see Davis and Hill,
1999; Hill et al., 2006). Thus, we investigated whether Piezo1
knockout might influence the caudal artery myogenic tone. Pres-
sure-dependent vasomotion was consistently present on top of
the myogenic response in stop-flow experiments (Figure S3A).
Myogenic response and vasomotion were also present when in-
traluminal flow was set at 15 ml/min, thus ruling out the possible
contribution of an accumulating diffusible factor in the lumen (n =
3; data not shown). Moreover, myogenic response and vasomo-
tion were observed in de-endothelized caudal arteries, while
vasodilation induced by acetylcholine was lost (n = 3; not
shown). Themyogenic response reached a plateau at a pressure
value of 50 mm Hg and further decreased in amplitude at pres-
sure above 125mmHg (Figure S3B). Themean amplitude of vas-
omotion presented a maximum at 25 mm Hg and then gradually
decreased at higher pressure values (Figure S3C). Remarkably,
no significant change was observed upon Piezo1 knockout on
either the myogenic response or pressure-dependent vasomo-
tion (Figures S3B and S3C). Furthermore, the passive diameter
measured in the absence of extracellular calcium and in the pres-
ence of vasorelaxants was unaffected in the absence of Piezo1
(Figure S3D). In addition, reactivity of the caudal artery to ago-
nists—either vasoconstrictors or the vasorelaxant acetylcho-
line—as well as vasoconstriction induced by KCl (80 mM), was
unaffected upon Piezo1 deletion (Figures S3E–S3I).
These results indicate that Piezo1-dependent SAC activity is
not required for the myogenic tone and reactivity to agonists of
the cutaneous caudal artery.
Piezo1 Is Dispensable for the Cerebral Artery
Myogenic Tone
The lack of effect of Piezo1 knockout on the myogenic tone was
confirmedwith the rostral cerebellar artery, another vascular bed
characterized by a high Piezo1 expression (Figure 1D). Again,
SAC activity was absent (0/23 for sm22Cre Piezo1/, as
compared to 10/12 for sm22Cre Piezo1+/+) in the isolated rostral
cerebellar artery myocytes from sm22Cre Piezo1/ mice,
although myogenic response was unaffected (Figures S4A–
S4C). Moreover, the passive arterial diameter of the rostral
cerebellar artery was not modified in the absence of Piezo1
(Figure S4D).
Thus, Piezo1 is dispensable for the active myogenic tone of
both caudal and cerebral arteries. Moreover, the lack of Piezo1
does not alter basal passive arterial diameter (i.e., in the absence
of extracellular calcium). Next, we tested whether the influence
of Piezo1 on arterial dimensions might be revealed at higher
blood pressure.orts 13, 1161–1171, November 10, 2015 ª2015 The Authors 1163
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Figure 3. Caudal Artery Remodeling Is Influ-
enced by Piezo1 in Hypertension
(A) Caudal artery sections are stained with orcein
from a saline-infused normotensive sm22Cre
Piezo1+/+ mouse.
(B) Same as in (A) but from a saline-infused
normotensive sm22Cre Piezo1/ mouse.
(C) Same as in (A) but from an Ang-II-infused hy-
pertensive sm22Cre Piezo1+/+ mouse.
(D) Same as in (A) but from an Ang-II-infused hy-
pertensive sm22Cre Piezo1/ mouse.
(E) Internal diameter.
(F) Wall thickness.
(G) CSAs are illustrated for sm22Cre Piezo1+/+
(white bars) and sm22Cre Piezo1/ (black bars)
arteries. Morphometric analysis has been per-
formed on caudal artery sections stained with or-
cein. Five caudal artery sections were analyzed per
mouse. Saline and hypertensive conditions (Ang II
or DOCA/salt/uninephrectomy) are indicated by
gray, magenta, and green horizontal bars, respec-
tively. Number of mice is indicated.
Data represent mean ± SEM. *p < 0.05; ***p <
0.001. NS, not significant.
See also Figure S5.Piezo1 Is Involved in Arterial Remodeling upon
Hypertension
We investigated whether the opening of Piezo1 in smooth mus-
cle cells might influence caudal artery remodeling upon hyper-
tension. We used an in vivo experimental model of chronic
hypertension involving angiotensin II (Ang II) infusion (Figures
S1G and S1H; Figures S1L and S1M). Arterial segments in the
absence of extracellular calcium and in the presence of the
vasorelaxant agents sodium nitroprusside and papaverine (i.e.,
without active tone) were fixed at 75 mm Hg for morphological
examination (Figure 3). In normotensive control conditions (sa-
line), homozygote smooth muscle Piezo1 deletion did not signif-
icantly affect caudal artery morphology, in line with our previous
measurements of passive diameter by arteriography (Figure 3;
Figure S3D). However, Piezo1 knockout in Ang-II-infused hyper-
tensive mice resulted in a significant reduction in arterial diam-
eter; wall thickness; and, consequently, cross-sectional area
(CSA) (Figure 3). We used a second in vivo model of hyperten-
sion, involving deoxycorticosterone acetate (DOCA)/salt/unin-
ephrectomy (Figures S1G and S1H; Figures S1L and S1M). In
the DOCA/salt/uninephrectomy hypertension model, arterial di-
mensions were unaffected in control animals, despite a strong
hypertensive effect (Figures 3E–3G; Figures S1L and S1M).
However, again, both diameter and wall thickness dramatically
decreased, resulting in a significant drop in CSA during DOCA/
salt/uninephrectomy hypertension in the absence of smooth
muscle Piezo1 (Figures 3E–3G). By labeling smooth muscle cells
with an antibody directed against sm22, we confirmed that
media thickness was reduced upon smPiezo1 deletion in the
DOCA/salt/uninephrectomy hypertension model, although the
endothelial cell layer was not visibly altered (Figures S5A and
S5B). Using Hoechst staining, we further estimated, by confocal
microscopy in thin sections, the number of nuclei present in the
media (Figures S5A and S5C). In the DOCA/salt/uninephrectomy1164 Cell Reports 13, 1161–1171, November 10, 2015 ª2015 The AusmPiezo1/ mice, the number of nuclei was significantly
decreased (Figure S5C). However, TUNEL staining, as well as
Ki67 immunolocalization were both negative after 3 weeks of
DOCA/salt/uninephrectomy hypertension in both smPiezo1+/+
and smPiezo1/ mice (data not shown), suggesting that in-
creased apoptosis and/or decreased proliferation upon Piezo1
deletion might have occurred at an earlier step during arterial
remodeling or, alternatively, that an altered recruitment/differen-
tiation from a non-smooth-muscle source might possibly be
involved. In addition, we estimated collagen I and III expression
in the arterial wall, taking advantage of Sirius red staining visual-
ized under polarized light (Figures S5D–S5G). The expression
of both collagen I and III isoforms was unchanged in the
DOCA/salt/uninephrectomy smPiezo1/ mice (Figures S5D–
S5G). Notably, the effect of Piezo1 knockout on arterial dimen-
sions tended to be correlated to blood pressure, with the
strongest effect seen in the DOCA/salt/uninephrectomy condi-
tion (Figures 3E–3G; Figures S1L and S1M).
These findings demonstrate that, at high blood pressure,
Piezo1 opening affects arterial structure (diameter and wall
thickness), unlike at normal blood pressure. Next, we investi-
gated whether an increase in the opening of Piezo1 in smooth
muscle cells might be sufficient to induce arterial remodeling,
independently of blood pressure. We took advantage of the
potent mechanoprotection of SACs by the cytoskeletal element
filamin A (FlnA) (Kainulainen et al., 2002; Sharif-Naeini et al.,
2009) to generate a conditional mouse model in which Piezo1
opening can be selectively enhanced in smooth muscle cells
but without the requirement of hypertension.
Smooth-Muscle-Specific and Conditional Deletion
of FlnA
Our previous work and those of others have indicated an impor-
tant role for the actin cytoskeleton in the down-modulation ofthors
mechanosensitive ion channels, including non-selective cationic
SACs and the K+-selective TREK/TRAAK channels (Kainulainen
et al., 2002; Lauritzen et al., 2005; Peyronnet et al., 2012;
Sharif-Naeini et al., 2009). Notably, the actin crosslinking
element FlnA exerts a tonic repression on the opening of SACs
(Kainulainen et al., 2002; Peyronnet et al., 2013; Sharif-Naeini
et al., 2009). We reasoned that selectively removing smooth
muscle FlnA (smFlnA) might lead to an increase in the opening
of Piezo1/SACs in arterial myocytes (i.e., loss of mechanopro-
tection), without the requirement of hypertension.
We used a tamoxifen (TAM)-inducible smMHCCre* system
to specifically and conditionally delete FlnA (smMHCCre*
FlnA0/, with or without Piezo1) in smooth muscle cells of adult
C57BL/6 male mice, thus ruling out the developmental effects
of the knockout (Feng et al., 2006; Wirth et al., 2008). qPCR ex-
periments revealed that TAM induction of smMHCCre* activity
resulted in a potent deletion of FlnA in caudal artery smoothmus-
cle cells (Figure S6A). Of note, deletion of FlnA did not influence
Piezo1mRNA expression, and vice versa (Figures S6A and S6C).
At the protein level, the turnover of this abundant cytoskeletal
element is remarkably slow, and a period of 12 weeks post-
TAM induction was required for complete removal of FlnA in
myocytes of the caudal artery (Figure S6B). Mouse viability,
weight, and size were not affected by specific deletion of FlnA
in smooth muscle cells at the adult stage, at least 12 weeks after
TAM induction (Figures S1I and S1J). Systolic arterial pressure
was mildly lowered upon smFlnA deletion, unlike diastolic pres-
sure (Figures S1N and S1O).
Thus, both FlnA and Piezo1 are highly expressed in the media
of the caudal artery (Figures 1B and 1C; Figures S6B and S6D).
Moreover, an efficient smooth-muscle-specific deletion of FlnA
and/or Piezo1 can be achieved conditionally at the adult stage
using the smMHCCre* line. Next, we examined the effect of
smFlnA knockout on the Piezo1 currents.
Piezo1 Activity Is Enhanced in the Absence of smFlnA
The amplitude of SAC currents induced by step increases in
pressure was significantly higher in myocytes from smMHCCre*
FlnA0/ mice at 12 weeks post-TAM induction, unlike at 2 and
6 weeks (Figure 4, gray circles). Remarkably, SAC currents in
caudal artery myocytes without FlnA were normalized when a
single Piezo1 allele was deleted (smMHCCre* FlnA0/ Piezo1+/;
Figure 4,magenta circles) but were fully suppressed upon homo-
zygote deletion of Piezo1 (smMHCCre* FlnA0/ Piezo1/; Fig-
ure 4E, red circles). Neither the single-channel current amplitude
nor the current kinetics, nor the open channel probability were
altered upon smFlnA deletion (Figures 4A and 4B; Figures S2D
and S2E), indicating that the number of active Piezo1 channels
is likely to be increased in the absence of smFlnA.
These findings demonstrate that Piezo1 activity in smoothmus-
cle cells of the caudal artery is significantly enhanced upon FlnA
deletion. Next, we examined whether this effect might be associ-
ated with a rise in cytosolic calcium since Piezo1 is a non-selec-
tive cationic channel permeable to calcium (Coste et al., 2010).
smFlnADeletion IncreasesCytosolic Calcium via Piezo1
Using ratiometric Fura-2 calcium imaging in isolated pressurized
caudal arteries, we observed that smFlnA deletion induced a sig-Cell Repnificant increase in cytosolic calcium (Figure 5, gray bar). How-
ever, Piezo1 deletion by itself (i.e., in the presence of smFlnA)
did not significantly alter intracellular calcium concentration (Fig-
ure 5, black bar). Remarkably, when FlnA was deleted together
with Piezo1 in smooth muscle cells, the rise in intracellular cal-
ciumwas absent (Figure 5, red bar). In the presence of nifedipine,
to avoid the possible contribution of L-type calcium channels,
cytosolic calcium remained elevated when smFlnA was deleted
alone (Figure 5, gray bar). However, without extracellular cal-
cium, this increase in cytosolic calcium upon FlnA deletion was
suppressed (Figure 5, gray bar).
These data indicate that deletion of smFlnA stimulates Piezo1
opening, which is associated with an increase in cytosolic cal-
cium. Next, we examined whether caudal artery morphology
might be altered in the absence of smFlnA, as anticipated if there
is a link between arterial remodeling and Piezo1 opening.
Inward Eutrophic Remodeling of theCaudal Artery in the
Absence of smFlnA
Mutations in the X-linked FlnA gene cause periventricular
nodular heterotopia (PH), resulting from an abnormal neuronal
migration from the periventricular region to the cortical area
and associated with epileptic seizures (Fox et al., 1998; Pous-
saint et al., 2000). Moreover, PH patients have a propensity for
aortic dilatation, aneurysms, abnormalities of the microcircula-
tion, and premature stroke (de Wit et al., 2009; Hart et al.,
2006; Parrini et al., 2006; Reinstein et al., 2013; Robertson,
2005; Sheen et al., 2005; Zhou et al., 2007). Thus, loss-of-func-
tion FlnA mutations also greatly affect the circulation.
Luminal diameter was not modified at 2 and 6 weeks after in-
duction of the smFlnA knockout with TAM (Figures S6E andS6F).
However, an inward remodeling was observed at 12 weeks post-
TAM induction (Figures S6B and S6G). There was a striking par-
allel between the increase in SAC activity (Figures 4C–4E) and
inward remodeling of the caudal artery, as a function of time after
TAM induction (Figures S6E–S6G). Histological examination
confirmed that internal diameter was reduced, while wall thick-
ness was increased,a resulting in a higher media/lumen ratio
without change in CSA (Figure 6, gray bars). Thus, smooth
muscle specific deletion of FlnA results in an inward eutrophic re-
modeling of the caudal artery, occurring in the absence of hyper-
tension. Next, we examined whether the increase in Piezo1
opening upon smFlnA deletion might influence this remodeling.
Role of Piezo1 in Caudal Artery Remodeling Induced by
smFlnA Deletion
We studied the effect of a smooth-muscle-specific double FlnA/
Piezo1 deletion (smMHCCre* FlnA0/ Piezo1/; Figure 6, red
bars) on caudal artery dimensions. By itself, smFlnA deletion
already led to a major inward remodeling (Figures 6B and 6D).
This decrease in arterial diameter in the absence of FlnA was
not affected by a combined deletion with Piezo1, while upon
Ang II or DOCA/salt/uninephrectomy hypertension (in the pres-
ence of smFlnA), the arterial diameter was preserved, and the
effect of Piezo1 deletion on arterial diameter was evident (Fig-
ure 3E). However, the increase in wall thickness in the absence
of smFlnA was fully reversed when either one or two alleles of
Piezo1 were deleted together with FlnA (Figures 6C and 6E,orts 13, 1161–1171, November 10, 2015 ª2015 The Authors 1165
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Figure 4. SAC Activity Is Enhanced in the Absence of smFlnA
(A) Mean SAC currents (at 80 mV) elicited in the cell-attached patch-clamp configuration in response to pressure pulses of increasing amplitude (shown in the
bottom trace) at 12 weeks post-TAM induction for control smMHCCre* FlnA0/+ Piezo1+/+ arterial myocytes.
(B) Same as in (A) but for smMHCCre* FlnA0/ Piezo1+/+ myocytes. Smooth muscle cells were isolated from caudal arteries of three different mice.
(C–E) Pressure-effect curves for SAC activity (holding potential: 80 mV) at (C) 2 weeks, (D) 6 weeks, and (E) 12 weeks post-TAM induction in arterial myocytes
from smMHCCre* FlnA0/+ Piezo1+/+ (white circles) and smMHCCre* FlnA0/ Piezo1+/+ (gray circles) caudal arteries. In (E), SAC activity for smMHCCre* FlnA0/
Piezo1+/ (magenta dots) and smMHCCre* FlnA0/ Piezo1/ (red dots) is also illustrated. Number of myocytes is indicated. The fitting parameters at 2 weeks
post-TAM induction were P0.5: 30.3 and k: 6.0 for smMHCCre* FlnA0/+ Piezo1+/+; and P0.5: 30.8 and k: 5.4 for smMHCCre* FlnA0/ Piezo1+/+. The fitting
parameters at 6 weeks post-TAM induction were P0.5: 22.6 and k: 7.8 for smMHCCre* FlnA0/+ Piezo1+/+; and P0.5: 20.9 and k: 4.0 for smMHCCre* FlnA0/
Piezo1+/+. The fitting parameters at 12 weeks post-TAM induction were P0.5: 24.6 and k: 7.4 for smMHCCre* FlnA0/+ Piezo1+/+; P0.5: 18.7 and k: 6.5 for
smMHCCre* FlnA0/ Piezo1+/+; and P0.5: 28.6 and k: 5.8 for smMHCCre* FlnA0/ Piezo1+/. I, mean current; P, pressure.
Data represent mean ± SEM. ***p < 0.001. NS, not significant.
See also Figure S2.magenta and red bars). Accordingly, the remodeling index me-
dia/lumen ratio and the CSA were dramatically reduced when
both Piezo1 and FlnA were inactivated at the same time in
smooth muscle cells (Figures 6F and 6G, magenta and red
bars). These findings were confirmed by labeling arterial myo-
cytes with an antibody directed against sm22 and by counting
the number of nuclei present in the media (Figures S5B and
S5C, gray and red columns). However, as previously described,
deletion of Piezo1 alone (i.e., in the presence of FlnA in smooth
muscle cells) did not significantly affect arterial dimensions (Fig-
ures 3E–3G, black bars).
These findings indicate that the increase in Piezo1 opening in
the absence of smFlnA (i.e., removal of mechanoprotection) in-
fluences arterial wall thickness, without a requirement for hyper-
tension. Next, we examined whether transglutaminases (TG),
calcium-dependent crosslinking enzymes previously reported1166 Cell Reports 13, 1161–1171, November 10, 2015 ª2015 The Auto be involved in the hypertension-dependent remodeling of
small arteries (Bakker et al., 2008; Engholm et al., 2011;
Huelsz-Prince et al., 2013), might be involved downstream of
Piezo1. Of note, TG requires the binding of up to six calcium
ions to be catalytically active (Bakker et al., 2008; Engholm
et al., 2011; Huelsz-Prince et al., 2013).
Stimulation of TG Activity in the Absence of smFlnA
Requires Piezo1
TG activity was measured by incorporation of the fluorescent
pseudo-substrate Alexa Fluor 647 cadaverine in whole caudal
arteries (Figure 7; Figure S7A). As a positive control, TG was
stimulated by the reducing agent DTT, and this activation was
reversed by cystamine (Figure S7A) (Castorena-Gonzalez
et al., 2014). TG activity in the smMHCCre* FlnA0/+ Piezo1/ ar-
teries (Figure 7B, black bar) was comparable to that in the controlthors
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Figure 5. Piezo1-Dependent Increase in Cytosolic Calcium upon
FlnA Deletion in Smooth Muscle Cells
Cytosolic calcium was monitored using Fura-2 ratiometric fluorescence im-
aging on isolated pressurized (50 mm Hg; intraluminal stop flow) caudal ar-
teries at 12 weeks post-TAM induction. After a control period in the presence
of extracellular calcium, arteries were bathed in the presence of 3 mM nifedi-
pine to inhibit voltage-dependent L-type calcium channels. Subsequently,
extracellular calcium was omitted, and 500 mM EGTA was added to the
bath solution. smMHCCre* FlnA0/+ Piezo1+/+ is indicated by white bars,
smMHCCre* FlnA0/ Piezo1+/+ is indicated by gray bars, smMHCCre* FlnA0/+
Piezo1/ is indicated by black bars, and smMHCCre* FlnA0/ Piezo1/
is indicated by red bars. Number of arteries is indicated. Data represent
mean ± SEM. *p < 0.05; ***p < 0.001.smMHCCre* FlnA0/+ Piezo1+/+ condition (Figures 7A and 7B). By
contrast, TG activity was significantly enhanced in caudal
arteries from smMHCCre* FlnA0/ Piezo1+/+ mice (Figure 7A;
Figure 7B, gray bar). However, qPCR and western blot analysis
revealed that TG2 expression was not altered in the smFlnA0/
caudal artery (Figures S7B and S7C). Remarkably, this stimula-
tion was fully reversed when Piezo1 was inactivated together
with FlnA (smMHCCre* FlnA0/ Piezo1/; Figure 7A; Figure 7B,
red bar). We confirmed this decrease in TG activity by Piezo1
deletion in the caudal artery from smFlnA0/ mice using a quan-
titative gel assay (Figures S7D and S7E). Even when a single
Piezo1 allele was deleted (smMHCCre* FlnA0/ Piezo1+/), TG
activity tended to be normalized in the absence of FlnA (Fig-
ure 7B, magenta bar).
These findings indicate that Piezo1 might be upstream of
TG activation in smooth muscle cells. Previous studies have
demonstrated that smooth muscle TG is potentially involved
in hypertension-dependent remodeling of resistance arteries
(Bakker et al., 2008; Huelsz-Prince et al., 2013). In addition,
an important role for TG2 was demonstrated on arterial smooth
muscle cell proliferation, with a key role in pulmonary artery hy-
pertension (DiRaimondo et al., 2014; Penumatsa et al., 2014).
Thus, we hypothesized that pharmacological inhibition of TG
with cystamine might phenocopy the effect of Piezo1 deletion
in smooth muscle cells. Next, we investigated whether in vivo
chronic inhibition of TG by a cystamine treatment might affect
the Piezo1-dependent arterial remodeling occurring in the
absence of smFlnA.Cell RepThe TG Inhibitor Cystamine Reverses Piezo1-
Dependent Arterial Remodeling
Cystamine (225 mg/kg/day) was added to the drinking water of
the mice for a period of 6 weeks. Cystamine treatment of both
control (smMHCCre* FlnA0/+ Piezo1+/+; white bars) and FlnA
knockout (smMHCCre* FlnA0/ Piezo1+/+; gray bars) had no
detectable effect on either diastolic or systolic blood pressure
(Figures S7F and S7G). The decrease in arterial diameter in the
absence of smFlnA was not altered by cystamine treatment (Fig-
ure 7C). However, the increase in wall thickness was completely
reversed, with, accordingly, a significant decrease in the media/
lumen ratio and CSA (Figures 7D–7F).
These findings suggest that TG contributes to the Piezo1-
dependent arterial remodeling in the absence of smFlnA.
DISCUSSION
Altogether, our findings indicate that Piezo1 in arterial myocytes
plays a role in the structural remodeling of small-diameter ar-
teries. In the cutaneous resistance caudal artery, smooth muscle
Piezo1 is associated with a trophic effect during hypertension
(i.e., whenmyocytes aremechanically stressed) or when channel
opening is enhanced at normal blood pressure in the absence of
smFlnA (i.e., without mechanoprotection). A role for SACs in
stressful conditions (i.e., hypertension) is reminiscent of the func-
tion of the mechanosensitive ion channels (MscS and MscL) in
bacteria (Booth, 2014; Haswell et al., 2011; Kung, 2005). Indeed,
the knockout of MscL and/or MscS does not affect basal bacte-
rial growth. However, those channels become critically required
for adaptation to an osmotic down-shock (i.e., environmental
stress) and their opening allows the release of osmolytes, which
prevents bacterial lysis (Booth, 2014; Haswell et al., 2011; Kung,
2005). Thus, both in arterial smooth muscle cells and bacteria,
mechanosensitive ion channels appear to be required for adap-
tive responses to stress.
Remarkably, no SAC activity was left in the absence of smooth
muscle Piezo1, demonstrating its central role in the mechano-
transduction of arterial myocytes. Piezo1 opening is repressed
by FlnA in smooth muscle cells. How might the cytoskeleton
network affect Piezo1 gating? The cortical cytoskeleton divides
the bilayer into submicrometer microdomains (the upholstery
model) (Sharif-Naeini et al., 2009). Disruption or softening of
the cytoskeleton, either chemically, mechanically, or genetically
(in the present case, by deleting the crosslinking element FlnA), is
likely to result in a larger radius of curvature of those microdo-
mains, leading to an increase in membrane stress and, thus,
sensitization of Piezo1 opening (Sharif-Naeini et al., 2009).
Upon smFlnA deletion, there is a striking temporal correlation
between remodeling of the caudal artery and the increase in
Piezo1 activity. Remarkably, normalization of SAC currents by
removing a single Piezo1 allele was sufficient to reverse the in-
crease in arterial wall thickness in the absence of smFlnA. Those
findings suggest that it is the increase in Piezo1 opening (either
induced by mechanical stress upon high blood pressure or by
removing FlnAmechanoprotection) that is responsible for arterial
remodeling, unlike the basal Piezo1 activity. The downstream
events linking Piezo1 activity to arterial remodeling probably
involve multiple effectors, which might possibly be activated byorts 13, 1161–1171, November 10, 2015 ª2015 The Authors 1167
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Figure 6. Deletion of Piezo1 in Smooth Muscle Cells Reduces Caudal Artery Wall Thickness in the Absence of FlnA
(A) Caudal artery section stained with orcein (left panel) and magnification of the wall (right panel) from a smMHCCre* FlnA0/+ Piezo1+/+ mouse.
(B) Same as in (A) but from a smMHCCre* FlnA0/ Piezo1+/+ mouse.
(C) Same as in (A) but from a smMHCCre* FlnA0/ Piezo1/ knockout mouse.
(D) Internal diameter.
(E) Wall thickness.
(F) Media/lumen ratio.
(G) CSAs are illustrated for control smMHCCre* FlnA0/+ Piezo1+/+ (white bars), smMHCCre* FlnA0/ Piezo1+/+ (gray bars), smMHCCre* FlnA0/ Piezo1+/
(magenta bars), and smMHCCre* FlnA0/ Piezo1/ (red bars) arteries. Five caudal artery sections were analyzed per mouse at 12 weeks post-TAM induction,
and the number of mice is indicated.
Data represent mean ± SEM. ***p < 0.001.
See also Figure S5.intracellular calcium, as previously reported for the protease cal-
pain-2 downstream of Piezo1 in the endothelium (Li et al., 2014).
Interestingly, pharmacological inhibition or genetic deletion of
the crosslinking enzyme TG2 has previously been shown to
impair or delay arterial inward remodeling of small arteries in
hypertensive conditions (Bakker et al., 2005, 2006; Engholm
et al., 2011). How TG is activated upon hypertension, where it
is active, and how it influences arterial remodeling are only start-
ing to emerge (Huelsz-Prince et al., 2013; van den Akker et al.,
2010). It has been recently hypothesized that mechanical force
within smooth muscle cells could be involved in regulating the
activity of TG during hypertension-dependent arterial remodel-
ing (Huelsz-Prince et al., 2013). Notably, in vivo chronic treat-
ment with the TG inhibitor cystamine, as well as Piezo1 deletion,
reversed the increase in arterial wall thickness in the absence
of smFlnA. Thus, our findings are supportive for a possible role
of Piezo1 in calcium-dependent TG activation within smooth
muscle cells.1168 Cell Reports 13, 1161–1171, November 10, 2015 ª2015 The AuBoth constitutive (sm22Cre) and inducible (smMHCCre*) sys-
tems used to delete Piezo1 in smooth muscle cells have their
own advantages and limitations (Frutkin et al., 2007; Moessler
et al., 1996; Wirth et al., 2008). Thus, one might expect some
common effects but also, eventually, some specific effects
when comparing both models. One consistent finding in our
study was an effect of Piezo1 on the arterial wall thickness, what-
ever the Cre driver or the experimental protocol used to induce
arterial remodeling (hypertension or deletion of smFlnA).
In conclusion, our findings indicate that smoothmuscle Piezo1
plays a key role in the structural remodeling of resistance arteries
upon hypertension or when mechanoprotection by FlnA is
removed. Recent elegant findings also demonstrate that Piezo1
fulfills an important function in the endothelium during early
development, where it is activated by shear stress (Li et al.,
2014; Ranade et al., 2014). Thus, Piezo1 is a key player in arterial
mechanotransduction, responding to both flow and pressure.
Here, we show that increased Piezo1 opening in smooth musclethors
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Figure 7. Increased Piezo1 Opening in the Absence of smFlnA Stimulates TG Activity
(A) The activity of TG in the caudal artery wall was reflected by the incorporation of the fluorescent pseudo-substrate cadaverine. smFlnA deletion at 12 weeks
post-TAM (smMHCCre* FlnA0/ Piezo1+/+) stimulates TG activity and this effect was reversed when Piezo1 was inactivated together with FlnA (smMHCCre*
FlnA0/ Piezo1/).
(B) TG activity was normalized to the control condition smMHCCre* FlnA0/+ Piezo1+/+ in each experiment to avoid any possible variation in the labeling and/or
imaging procedures. smMHCCre* FlnA0/+ Piezo1/ is indicated by black bars, smMHCCre* FlnA0/ Piezo1+/+ is indicated by gray bars, smMHCCre* FlnA0/
Piezo1+/ is indicated by magenta bars, and smMHCCre* FlnA0/ Piezo1/ in red bars.
(C) Internal diameter.
(D) Wall thickness.
(E) Media/lumen ratio.
(F) CSAs are illustrated for smMHCCre* FlnA0/+ Piezo1+/+ (white bars) and smMHCCre* FlnA0/ Piezo1+/+ (gray bars) arteries in control conditions or chronically
treated with cystamine (equivalent to 225 mg/kg/day) added to the drinking water for 6 weeks (starting at 6 weeks post-TAM induction). Morphometric analysis
has been performed on caudal artery sections stained with orcein. Five caudal artery sections were analyzed per mouse. Control (water) and cystamine con-
ditions are indicated by black and blue horizontal bars, respectively. Number of mice is indicated.
Data represent mean ± SEM. ***p < 0.001.
See also Figure S7.cells conditions the structural remodeling of small-diameter ar-
teries. Since arterial remodeling is now recognized as a major
prognostic marker in patients at high cardiovascular risk, Piezo1
may represent an interesting pharmacological target for the
treatment of hypertensive conditions (Mathiassen et al., 2007;
Rizzoni et al., 2003).
EXPERIMENTAL PROCEDURES
Knockout Mice
sm22Cre Piezo1/ Mice
For constitutive smooth-muscle-specific Piezo1 deletion, the sm22Cre line
(Tg(Tagln-cre)1Her, Jackson Laboratories) was initially crossed with Pie-Cell Repzo1lox/lox mice and further bred to yield the sm22Cre Piezo1/ mice.
Although recombination also occurs during embryogenesis in some cardio-
myocytes, a major advantage for this constitutive sm22Cre driver is that
there is no recombination in either visceral smooth muscle cells or veins
(Moessler et al., 1996). Considering that Piezo1 mRNA expression is partic-
ularly low in the mouse heart and that the transient sm22 expression in the
developing heart is spatially restricted to the presumptive right ventricle,
the impact on the systemic circulation of an eventual Piezo1-dependent
cardiac dysfunction is very unlikely (Coste et al., 2010; Moessler et al.,
1996). In the control group, we included both Piezo1lox/lox and sm22Cre
mice, and since no significant difference was observed between both geno-
types, data were merged (controls indicated by sm22Cre Piezo1+/+). The
genetic background was C57BL/6, and 20-week-old adult male mice
were used for this study.orts 13, 1161–1171, November 10, 2015 ª2015 The Authors 1169
smMHCCre* Piezo1/Mice
For conditional smooth-muscle-specific Piezo1 knockout, Piezo1lox/lox female
mice were initially crossed with the TAM-inducible smMHCCre-ER(T2) male
mice (inducible Cre* is inserted in the Y chromosome (Wirth et al., 2008))
and further bred to yield the smMHCCre* Piezo1/ male mice. Twelve-
week-old adult male mice were injected twice intraperitoneally with TAM
(50 mg/kg/day dissolved in peanut oil, EtOH 10%). Of note, the smMHC-
Cre* transgene is also expressed in visceral smooth muscle cells, although
not in the heart (Frutkin et al., 2007; Wirth et al., 2008). In the control group,
we included Piezo1lox/lox and smMHCCre* mice injected with TAM, and since
no significant difference was observed between both genotypes, data were
merged (controls indicated by smMHCCre* Piezo1+/+). Mice were studied
12 weeks after TAM injection. TAM-injected heterozygote and homozygote
smooth-muscle-specific Piezo1 knockout mice are indicated by smMHCCre*
Piezo1+/ and smMHCCre* Piezo1/, respectively.
smMHCCre* FlnA0/ Mice
TAM-inducible smMHCCre* male mice were crossed with female FlnAlox/lox
mice to achieve a smooth-muscle-specific deletion of FlnA at the adult stage
(smMHCCre* FlnA0/), thus avoiding developmental effects of the knockout
(Feng et al., 2006). Of note, male mice are hemizygotes for FlnA, as the gene
is on the X chromosome (FlnA0/+). Mice were backcrossed at least 12 times
onto a C57BL/6 background. Protocol for TAM injection was as described
earlier for Piezo1 deletion. For generating double FlnA and Piezo1 KO mice,
smMHCCre* FlnA0/ male mice were crossed with female Piezo1lox/lox mice
and further bred to yield the smMHCCre* FlnA0/ Piezo1/ male mice.
Statistics
Significance of the differences was tested with a permutation test (R Develop-
ment Core Team: http://www.r-project.org/) (n < 30) or two-sample Student’s
t test (n > 30). One asterisk indicates p < 0.05; two asterisks indicate p < 0.01,
and three asterisks indicate p < 0.001. Data represent mean ± SEM. N indi-
cates the number of mice studied, and n indicates the number of cells or
arteries.
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